{
    "pubmed_id": 35148837,
    "study_identifier": "PMID35148837_study-01",
    "study_name": "Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination",
    "publication_title": "Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination",
    "study_objective": "To investigate whether antibodies stimulated by mRNA vaccination (BNT162b2), including third-dose boosting, differ from those generated by infection or adenoviral (ChAdOx1-S and Gam-COVID-Vac) or inactivated viral (BBIBP-CorV) vaccines.",
    "study_description": "During the SARS-CoV-2 pandemic, novel and traditional vaccine strategies have been deployed globally. We investigated whether antibodies stimulated by mRNA vaccination (BNT162b2), including third-dose boosting, differ from those generated by infection or adenoviral (ChAdOx1-S and Gam-COVID-Vac) or inactivated viral (BBIBP-CorV) vaccines. We analyzed human lymph nodes after infection or mRNA vaccination for correlates of serological differences. Antibody breadth against viral variants is lower after infection compared with all vaccines evaluated but improves over several months. Viral variant infection elicits variant-specific antibodies, but prior mRNA vaccination imprints serological responses toward Wuhan-Hu-1 rather than variant antigens. In contrast to disrupted germinal centers (GCs) in lymph nodes during infection, mRNA vaccination stimulates robust GCs containing vaccine mRNA and spike antigen up to 8 weeks postvaccination in some cases. SARS-CoV-2 antibody specificity, breadth, and maturation are affected by imprinting from exposure history and distinct histological and antigenic contexts in infection compared with vaccination.",
    "primary_institution_name": "Stanford University",
    "study_personnel": [
        {
            "personnel_id": "PMID35148837_personnel-01",
            "honorific": "",
            "last_name": "Scott",
            "first_name": "Boyd",
            "suffixes": "",
            "organization": "Stanford University",
            "orchid_id": "",
            "email": "sboyd1@stanford.edu",
            "seronet_title_in_study": "SeroNet Principal Investigator",
            "role_in_study": "Principal Investigator",
            "site_name": "Stanford University"
        }
    ],
    "study_file": [
        {
            "study_file_name": "PMID35148837_v1.2.5.xlsm",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors.",
            "study_file_type": "Study Summary Description"
        }
    ],
    "study_link": [
        {
            "link_name": "Mendeley Data",
            "value": "https://data.mendeley.com/datasets/j8r94pfrj6/1"
        },
        {
            "link_name": "original code",
            "value": "https://doi.org/10.5281/zenodo.5854880"
        },
        {
            "link_name": " Github repository",
            "value": "https://github.com/boyd-lab/covid-infection-vs-vaccination"
        }
    ],
    "research_focus": "Immune Response",
    "study_type": "Clinical Research",
    "keyword": [
        "Astra Zeneca",
        "BBIBP-CorV",
        "BNT162b2; BioNTech-Pfizer",
        "COVID-19",
        "ChAdOx1-S",
        "Delta variant",
        "Gam-COVID-Vac",
        "Moderna",
        "SARS-CoV-2 variants of concern",
        "Sinopharm",
        "Sputnik V",
        "antibodies",
        "autopsy",
        "imprinting",
        "lymph node germinal center",
        "mRNA-1273"
    ],
    "clinical_study_design": "Cross-sectional Study",
    "in_silico_model_type": "",
    "protocol": {
        "protocol_id": "PMID35148837_protocol-01",
        "protocol_file_name": "PMID35148837_protocol-01.txt",
        "protocol_name": "PMID35148837_protocol-01",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19 | SARS-CoV-2 Alpha; B.1.1.7 | SARS-CoV-2 Delta; B.1.617.2"
    ],
    "sars_cov_2_vaccine_type": [
        "Pfizer-BioNTech",
        "Moderna",
        "AstraZeneca",
        "Sputnik V",
        "Sinopharm"
    ],
    "clinical_outcome_measure": "",
    "enrollment_start_date": "",
    "enrollment_end_date": "",
    "number_of_study_subjects": 527,
    "age_unit": "Years",
    "minimum_age": 1,
    "maximum_age": 95,
    "study_human_cohort": [
        {
            "arm_id": "PMID35148837_human_subject-01",
            "arm_name": "Subjects received Pfizer BNT162b2 vaccine",
            "study_population_description": "59 individuals received Pfizer BNT162b2 vaccine",
            "arm_type": "Vaccination",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": [],
            "assessment_name": "",
            "study_location": [
                "CA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Vaccinated"
            ],
            "sars_cov_2_vaccine_type": [
                "Pfizer BioNTech COVID-19 vaccine ; VO:0004987"
            ],
            "covid_19_disease_severity": [
                "Unknown"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35148837_human_subject-02",
            "arm_name": "Patients with COVID-19",
            "study_population_description": "100 patients enrolled in Stanford COVID-19 patient cohort 1",
            "arm_type": "Treatment Arm",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": [],
            "assessment_name": "",
            "study_location": [
                "CA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Post-acute sequelae of COVID-19 (>= 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "Self Reported"
            ],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Moderate",
                "Severe"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35148837_human_subject-03",
            "arm_name": "Patients with COVID-19",
            "study_population_description": "74 patients enrolled in Stanford COVID-19 patient cohort 2",
            "arm_type": "No Intervention Arm",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": [],
            "assessment_name": "",
            "study_location": [
                "CA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Post-acute sequelae of COVID-19 (>= 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "Self Reported"
            ],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "N/a"
            ],
            "covid_19_disease_severity": [
                "Mild",
                "Moderate",
                "Severe"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35148837_human_subject-04",
            "arm_name": "Patients with COVID-19",
            "study_population_description": "41 patients enrolled in Stanford SARS-CoV-2 variant infection cohort",
            "arm_type": "No Intervention Arm",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": [],
            "assessment_name": "",
            "study_location": [
                "CA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Post-acute sequelae of COVID-19 (>= 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "Self Reported"
            ],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Severe"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35148837_human_subject-05",
            "arm_name": "Subjects received Vaccine",
            "study_population_description": "196 Mongolian vaccine study participants received BioNTech-Pfizer BNT162b2, AstraZeneca ChAdOx1-S, Sputnik V Gam-COVID-Vac, and Sinopharm BBIBP-CorV vaccines",
            "arm_type": "Vaccination",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": [],
            "assessment_name": "",
            "study_location": [
                "CA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Vaccinated"
            ],
            "sars_cov_2_vaccine_type": [
                "Pfizer BioNTech COVID-19 vaccine; VO:0004987",
                "Oxford\u2013AstraZeneca COVID-19 vaccine; VO:0005158",
                "Sputnik V; VO:0005163",
                "Sinopharm (BBIBP-CorV); VO:0005166"
            ],
            "covid_19_disease_severity": [
                "Unknown"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35148837_human_subject-06",
            "arm_name": "Healthy human control",
            "study_population_description": "57 subjects enrolled",
            "arm_type": "No Intervention Arm",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Not specified"
            ],
            "age_event": "Not Specified",
            "subject_phenotype": [],
            "assessment_name": "",
            "study_location": [
                "CA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Uninfected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Unknown"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35148837_human_subject-07",
            "arm_name": "Patients with COVID-19",
            "study_population_description": "Biopsies collected from patients who died of COVID-19",
            "arm_type": "No Intervention Arm",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Not Specified",
            "subject_phenotype": [],
            "assessment_name": "",
            "study_location": [
                "CA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Post-acute sequelae of COVID-19 (>= 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "Self Reported"
            ],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Death"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35148837_human_subject-08",
            "arm_name": "Subjects received mRNA Vaccine",
            "study_population_description": "Biopsies collected from BNT162b2 or mRNA-1273 vaccinees",
            "arm_type": "Vaccination",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Not Specified",
            "subject_phenotype": [],
            "assessment_name": "",
            "study_location": [
                "CA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Vaccinated"
            ],
            "sars_cov_2_vaccine_type": [
                "Moderna COVID-19 vaccine ; VO:0005157, Pfizer BioNTech COVID-19 vaccine ; VO:0004987"
            ],
            "covid_19_disease_severity": [
                "Death"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [],
    "planned_visit": [
        {
            "visit_id": "PMID35148837_visit-01",
            "visit_name": "Blood sample collected from Pfizer BNT162b2 vaccinated individuals",
            "visit_order_number": 1,
            "visit_min_start_day": 0,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-02",
            "visit_name": "Blood sample collected from Pfizer BNT162b2 vaccinated subjects",
            "visit_order_number": 2,
            "visit_min_start_day": 6,
            "visit_max_start_day": 8,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-03",
            "visit_name": "Blood samples collected from Pfizer BNT162b2 vaccinated individuals",
            "visit_order_number": 3,
            "visit_min_start_day": 19,
            "visit_max_start_day": 22,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-04",
            "visit_name": "Blood and saliva samples collected from Pfizer BNT162b2 vaccinated individuals",
            "visit_order_number": 4,
            "visit_min_start_day": 40,
            "visit_max_start_day": 44,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-05",
            "visit_name": "Blood sample collected from Pfizer BNT162b2 vaccinated subjects",
            "visit_order_number": 5,
            "visit_min_start_day": 90,
            "visit_max_start_day": 120,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-06",
            "visit_name": "Blood samples collected from Pfizer BNT162b2 vaccinated individuals",
            "visit_order_number": 6,
            "visit_min_start_day": 200,
            "visit_max_start_day": 220,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-07",
            "visit_name": "Blood sample collected from Pfizer BNT162b2 vaccinated subjects after the third dose boost",
            "visit_order_number": 7,
            "visit_min_start_day": 0,
            "visit_max_start_day": 3,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-08",
            "visit_name": "Blood sample collected from Pfizer BNT162b2 vaccinated subjects after the third dose boost",
            "visit_order_number": 8,
            "visit_min_start_day": 7,
            "visit_max_start_day": 10,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-09",
            "visit_name": "Blood sample collected from Pfizer BNT162b2 vaccinated subjects after the third dose boost",
            "visit_order_number": 9,
            "visit_min_start_day": 20,
            "visit_max_start_day": 22,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-10",
            "visit_name": "Blood sample collected from Pfizer BNT162b2 vaccinated subjects after the third dose boost",
            "visit_order_number": 10,
            "visit_min_start_day": 28,
            "visit_max_start_day": 30,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMI35148837_visit-11",
            "visit_name": "Lymph node biopsy collected from1 to 8 weeks of Pfizer BNT162b2 and Moderna mRNA-1273 vaccinated individuals",
            "visit_order_number": 11,
            "visit_min_start_day": 7,
            "visit_max_start_day": 60,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-12",
            "visit_name": "Peribronchial lymph node biopsy collected from 1 to  3 weeks after COVID symptoms onset in patients who died of COVID",
            "visit_order_number": 12,
            "visit_min_start_day": 7,
            "visit_max_start_day": 21,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35148837_visit-13",
            "visit_name": "Blood sample collected from BioNTech-Pfizer, AstraZeneca, Sputnik V, and Sinopharm vaccinees after second vaccine dose",
            "visit_order_number": 13,
            "visit_min_start_day": 0,
            "visit_max_start_day": 120,
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID35148837_human_subject-01 | PMID35148837_human_subject-02 | PMID35148837_human_subject-03 | PMID35148837_human_subject-04 | PMID35148837_human_subject-05 | PMID35148837_human_subject-06 | PMID35148837_human_subject-07 | PMID35148837_human_subject-08"
            ],
            "associated_first_planned_visit_id": [
                "PMID35148837_visit-01 | PMID35148837_visit-02 | PMID35148837_visit-03 | PMID35148837_visit-04 | PMID35148837_visit-05 | PMID35148837_visit-06 | PMID35148837_visit-07 | PMID35148837_visit-08 | PMID35148837_visit-09 | PMID35148837_visit-10 | PMID35148837_visit-11 | PMID35148837_visit-12 | PMID35148837_visit-13"
            ],
            "assay_type": [
                "Pseudovirus Neutralization Assay"
            ],
            "experiment_name": [
                "Pseudovirus Neutralization Assay"
            ],
            "experiment_results_file_name": [],
            "biospecimen_type": [
                "Blood",
                "Saliva"
            ],
            "sars_cov_2_antigen": [
                "Receptor Binding Domain (RBD)"
            ],
            "assay_use": [],
            "manufacture": [
                "Meso Scale Diagnostics"
            ],
            "catalog_number": [],
            "virus_target": [
                "SARS-CoV-2 Alpha; B.1.1.7",
                "SARS-CoV-2 Delta; B.1.617.2"
            ],
            "antibody_isotype": [
                "IgG; IgA; IgM"
            ],
            "reporting_units": [],
            "assay_reporting_format": []
        },
        {
            "arm_id": [
                "PMID35148837_human_subject-01 | PMID35148837_human_subject-02 | PMID35148837_human_subject-03 | PMID35148837_human_subject-04 | PMID35148837_human_subject-05 | PMID35148837_human_subject-06 | PMID35148837_human_subject-07 | PMID35148837_human_subject-08"
            ],
            "associated_first_planned_visit_id": [
                "PMID35148837_visit-01 | PMID35148837_visit-02 | PMID35148837_visit-03 | PMID35148837_visit-04 | PMID35148837_visit-05 | PMID35148837_visit-06 | PMID35148837_visit-07 | PMID35148837_visit-08 | PMID35148837_visit-09 | PMID35148837_visit-10 | PMID35148837_visit-11 | PMID35148837_visit-12 | PMID35148837_visit-13"
            ],
            "assay_type": [
                "PCR"
            ],
            "experiment_name": [
                "PCR"
            ],
            "experiment_results_file_name": [],
            "biospecimen_type": [
                "Blood",
                "Saliva"
            ],
            "sars_cov_2_antigen": [
                "Full Length Spike Trimer"
            ],
            "assay_use": [],
            "manufacture": [
                "Meso Scale Diagnostics"
            ],
            "catalog_number": [],
            "virus_target": [
                "SARS-CoV-2 Alpha; B.1.1.7",
                "SARS-CoV-2 Delta; B.1.617.2"
            ],
            "antibody_isotype": [
                "IgG"
            ],
            "reporting_units": [],
            "assay_reporting_format": []
        },
        {
            "arm_id": [
                "PMID35148837_human_subject-01 | PMID35148837_human_subject-02 | PMID35148837_human_subject-03 | PMID35148837_human_subject-04 | PMID35148837_human_subject-05 | PMID35148837_human_subject-06 | PMID35148837_human_subject-07 | PMID35148837_human_subject-08"
            ],
            "associated_first_planned_visit_id": [
                "PMID35148837_visit-01 | PMID35148837_visit-02 | PMID35148837_visit-03 | PMID35148837_visit-04 | PMID35148837_visit-05 | PMID35148837_visit-06 | PMID35148837_visit-07 | PMID35148837_visit-08 | PMID35148837_visit-09 | PMID35148837_visit-10 | PMID35148837_visit-11 | PMID35148837_visit-12 | PMID35148837_visit-13"
            ],
            "assay_type": [
                "Immunohistochemistry"
            ],
            "experiment_name": [
                "Immunohistochemistry"
            ],
            "experiment_results_file_name": [],
            "biospecimen_type": [
                "Multiple Immune Cell Types (of respiratory tract)"
            ],
            "sars_cov_2_antigen": [
                "Nucleocapsid"
            ],
            "assay_use": [],
            "manufacture": [
                "Meso Scale Diagnostics"
            ],
            "catalog_number": [],
            "virus_target": [
                "SARS-CoV-2 Alpha; B.1.1.7",
                "SARS-CoV-2 Delta; B.1.617.2"
            ],
            "antibody_isotype": [
                "IgG"
            ],
            "reporting_units": [],
            "assay_reporting_format": []
        },
        {
            "arm_id": [
                "PMID35148837_human_subject-01 | PMID35148837_human_subject-02 | PMID35148837_human_subject-03 | PMID35148837_human_subject-04 | PMID35148837_human_subject-05 | PMID35148837_human_subject-06 | PMID35148837_human_subject-07 | PMID35148837_human_subject-08"
            ],
            "associated_first_planned_visit_id": [
                "PMID35148837_visit-01 | PMID35148837_visit-02 | PMID35148837_visit-03 | PMID35148837_visit-04 | PMID35148837_visit-05 | PMID35148837_visit-06 | PMID35148837_visit-07 | PMID35148837_visit-08 | PMID35148837_visit-09 | PMID35148837_visit-10 | PMID35148837_visit-11 | PMID35148837_visit-12 | PMID35148837_visit-13"
            ],
            "assay_type": [
                "Chemiluminescent Assay"
            ],
            "experiment_name": [
                "Electrochemiluminescence Assay"
            ],
            "experiment_results_file_name": [],
            "biospecimen_type": [
                "Multiple Immune Cell Types (of respiratory tract)"
            ],
            "sars_cov_2_antigen": [
                "N-terminal Domain (NTD)"
            ],
            "assay_use": [],
            "manufacture": [
                "Meso Scale Diagnostics"
            ],
            "catalog_number": [],
            "virus_target": [
                "SARS-CoV-2 Alpha; B.1.1.7",
                "SARS-CoV-2 Delta; B.1.617.2"
            ],
            "antibody_isotype": [
                "IgG; IgA; IgM"
            ],
            "reporting_units": [],
            "assay_reporting_format": []
        },
        {
            "arm_id": [
                "PMID35148837_human_subject-01 | PMID35148837_human_subject-02 | PMID35148837_human_subject-03 | PMID35148837_human_subject-04 | PMID35148837_human_subject-05 | PMID35148837_human_subject-06 | PMID35148837_human_subject-07 | PMID35148837_human_subject-08"
            ],
            "associated_first_planned_visit_id": [
                "PMID35148837_visit-01 | PMID35148837_visit-02 | PMID35148837_visit-03 | PMID35148837_visit-04 | PMID35148837_visit-05 | PMID35148837_visit-06 | PMID35148837_visit-07 | PMID35148837_visit-08 | PMID35148837_visit-09 | PMID35148837_visit-10 | PMID35148837_visit-11 | PMID35148837_visit-12 | PMID35148837_visit-13"
            ],
            "assay_type": [
                "Other"
            ],
            "experiment_name": [
                "Antigen Testing"
            ],
            "experiment_results_file_name": [],
            "biospecimen_type": [
                "Blood",
                "Saliva"
            ],
            "sars_cov_2_antigen": [
                "Other"
            ],
            "assay_use": [],
            "manufacture": [
                "Meso Scale Diagnostics"
            ],
            "catalog_number": [],
            "virus_target": [
                "SARS-CoV-2 Alpha; B.1.1.7",
                "SARS-CoV-2 Delta; B.1.617.2"
            ],
            "antibody_isotype": [
                "Other"
            ],
            "reporting_units": [],
            "assay_reporting_format": []
        }
    ],
    "geriatric_subjects": "Y",
    "pediatric_subjects": "Y",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID35148837_inexcl-01",
            "inclusion_criterion": "Geriatric subjects",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35148837_inexcl-02",
            "inclusion_criterion": "SARS-CoV-2 Antibodies Measured",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35148837_inexcl-03",
            "inclusion_criterion": "Pediatric subjects",
            "inclusion_criterion_category": "inclusion"
        }
    ]
}
